Know Cancer

or
forgot password

    • cancer clinical trials in york, ME

    • Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Lung Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    York Hospital
    York, Maine 03909
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    York Hospital
    York, Maine 03909
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    York Hospital
    York, Maine 03909
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    York Hospital
    York, Maine 03909
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    York Hospital
    York, Maine 03909
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    York Hospital
    York, Maine 03909
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    York Hospital
    York, Maine 03909
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Pharmatech Oncology Study Site
    York, Maine 03909
    Diffuse Large B-Cell Lymphoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    York Hospital
    York, Maine 03909
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Lung Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Kidney Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    York Hospital
    York, Maine 03909
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    York Hospital's Oncology Treatment Center
    York, Maine 03909
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
    York Hospital
    York, Maine 03909
    Pegfilgrastim-induced Back and Leg Pain
    Erlotinib Hydrochloride and Cabozantinib Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    York Hospital
    York, Maine 03909
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer